Reserpine contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AK}}
{{CMG}}; {{AE}} {{AK}}


CONTRAINDICATIONS
==CONTRAINDICATIONS==


Known [[hypersensitivity]], mental depression or history of mental [[depression ]](especially with suicidal tendencies), active[[ peptic ulcer]], [[ulcerative colitis]], and patients receiving [[electroconvulsive therapy]].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RESERPINE TABLET [EON LABS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462 | publisher =  | date =  | accessdate = 7 March 2014 }}</ref>
Known [[hypersensitivity]], mental depression or history of mental [[depression ]](especially with suicidal tendencies), active[[ peptic ulcer]], [[ulcerative colitis]], and patients receiving [[electroconvulsive therapy]].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = RESERPINE TABLET [EON LABS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462 | publisher =  | date =  | accessdate = 7 March 2014 }}</ref>

Revision as of 15:52, 7 March 2014

Reserpine
Reserpine® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Reserpine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

CONTRAINDICATIONS

Known hypersensitivity, mental depression or history of mental depression (especially with suicidal tendencies), activepeptic ulcer, ulcerative colitis, and patients receiving electroconvulsive therapy.[1]

References

  1. "RESERPINE TABLET [EON LABS, INC.]". Retrieved 7 March 2014.